1 / 2

Results

0 MIN. 30 MIN. 5 MIN. 60 MIN. 10 MIN. 60 MIN NO CoF. 20 MIN. Incubate @ 37°C 0, 5, 10, 20, 30, 60 min. 350.00. 300.00. y = 1.2534x - 2.1081. 2. R. = 0.8603. 250.00. 200.00. Literature Cl int. 150.00. y = 1.2401x - 2.5148. 2. R. = 0.8171. 100.00. 50.00. ALH. FX.

giulio
Download Presentation

Results

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. 0 MIN 30 MIN 5 MIN 60 MIN 10 MIN 60 MIN NO CoF 20 MIN Incubate @ 37°C 0, 5, 10, 20, 30, 60 min. 350.00 300.00 y = 1.2534x - 2.1081 2 R = 0.8603 250.00 200.00 Literature Clint 150.00 y = 1.2401x - 2.5148 2 R = 0.8171 100.00 50.00 ALH FX 0.00 0.00 50.00 100.00 150.00 200.00 250.00 Experimental Clint A B A+B ON DECK INCUBATION AND 384-WELL FORMAT SIMPLIFY AND INCREASE THROUGHPUT FOR HUMAN LIVER MICROSOMAL SCREENING IN AN HT-ADME SCREENING LABORATORY M. Snyder, C. Taylor, J. Janiszewski & K. Whalen - PDM, Pfizer Global Research and Development, Groton Laboratories, Groton, CT 06340 Overview Introduction Results E • Introduction • To develop an automated 384-well microsomal metabolic stability assay to support rapid screening of 2,000 discovery compounds per week. • Methods • Biology: • Twelve compounds with a broad range of clearance rates and P450 pathways were chosen to validate assay1,2. • Eight plates were generated per 384-well master plate: a matrix blank; 0, 5, 10, 20, 30, 60 minute timepoints; and a 60 minute no co-factor control. • Assay volume: 27.8 µl. Automation/Bioanalytical: • Caliper Life Sciences Sciclone ALH3000 and Beckman Coulter Biomek FX workstations equipped with 384-channel disposable tip array were used to perform all liquid handling steps. • An AB/Sciex API3000 triple quadrupole mass spectrometer, operating in selected reaction monitoring (SRM) mode, was used for analyte and internal standard detection. • Results • Validation results were assessed relative to published clearance values. • Key learning’s: • Rapid Dispense (100 µl /sec) • On-deck Incubation • Scheduling with Excel Macro • The experimental results correlated well to the literature values (Figure 4). The larger discrepancies may be attributed to the differing incubation conditions (e.g. protein concentration). • Little difference in workstations (Figure 5). • The combination of 384-well format and automated liquid handling allows for 720 test compounds to be assayed in a single morning. This format equates to a potential 3-day throughput of over 4300 compounds. • Further throughput gains are restricted by LC/MS/MS analysis. (i.e. 4300 compounds = 43,000 LC injections) • The large capacity allows us to maintain discovery chemistry’s capacity of over 2000 compounds per week. In drug discovery, the number of chemical compounds requiring in-vitro ADME screening is ever increasing. To keep pace with compound submissions, new methods must be developed to increase the throughput of current in-vitro ADME assays. Herein, we present our group’s efforts towards increasing throughput of the Human Liver Microsome metabolic stability assay using a compressed 384-well format and an automated liquid handler. B D C ACN & IS TIP BOX A Methods: Microsome Assay Specifics 250.00 Amitriptyline Figure 2.Sciclone Deck Layout. (A) Two 6-position Mecour heating blocks, (B) Recirculating reservoir containing cold acetonitrile and IS, (C) Microsome reservoir, (D) 384-well tip-wash station, (E) Extra deck space where crashed plates are moved off of heat. Desipramine Propafenone Propranolol Nicardipine Midazolam Prednisone Verapamil Diclofenac Dilitiazem Quinidine Diazepam 200.00 • P450 concentration: 0.25 µM (0.76 mg protein/mL) • Compound substrate concentration: 1 µM • Co-Factor utilizes NADPH regeneration system w/ 1 mM MgCl2 • Buffer concentration: 100 mM KPO4, pH 7.4 • Time-points: 0, 5, 10, 20, 30 and 60 minutes • Internal standard used to ensure LC/MS/MS performance and reproducibility • Liquid handling performed on Caliper Life Sciences Sciclone ALH3000 or Beckman Coulter Biomek FX workstation 150.00 Biomek FX Clint 100.00 y = 0.9416x + 1.3742 2 R = 0.9226 50.00 0.00 0.00 50.00 100.00 150.00 200.00 250.00 Sciclone ALH 3000 Clint D Figure 5.Different pipetting techniques and on-deck incubation provided similar Cl int values on either workstation. Figure 4. Intrinsic clearance values for 12 compounds (n=96) run on both automated workstations were similar to reported values. B C 2. 4. ACN (Protein Precip.) Microsomes & Cofactor A Table 1.Measured temperature variation for on-deck incubation hardware. 25 µl 75 µl 1. 34 µl/sec 100 µl/sec Figure 3.FX Deck Layout. (A) 3 X 4 Peltier heating ALP, (B) Recirculating reservoir containing cold acetonitrile and IS, (C) Microsome reservoir, (D) 384-well tip-wash station, (E) Extra deck space where crashed plates are stacked off of heat not shown. Figure 6. Non-contact mixing. Table 2.Excel scheduling macro used with Sciclone for time-point incubations. Written by Jim Batchelor, Caliper Life Sciences. 2.8 µl Assay (8) Compound Conclusions: Key Learning’s References • Rapid Dispense/ Non-contact Mixing 100 µl/sec - Savings in Tips, Time, & Deck Space (Figure 6). • On-Deck Incubation @ 37°C • Savings in Hardware/ Human Intervention (Table 1). • Easy Scheduling with Excel Macro (Table 2). • 27.8 µl Assay in 384 well plate • Savings in Microsomes - 720 Compounds in 3 hours! 3. • Riley Robert J; McGinnity D F; Austin R P. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes. Drug Metab and Dispos (2005), 33(9), 1304-11. • Obach, R. Scott. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab and Dispos (1999), 27(11), 1350-1359. Figure 1. 27.8 µl assay.

  2. Rapid Dispense Speed 100 ul/sec Deck space, tips ($$$$) On-deck Incubation Mecour Thermal Blocks Temp range 5.4 vs. 1.2°C Easy Scheduling Excel Macro Success & Key Learning's from Microsome Assay Automation 34 ul/sec 100 ul/sec • Success: • Automated dilution during Mic prep • 1 hour unattended completion of assay

More Related